Bentham Science Logo

Clinical Cancer Drugs

Volume 6, 2 Issues, 2019
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

Contents

Clinical Cancer Drugs, Volume 3 - Number 2


Review Article

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

, 3(2): 76 - 86

Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter


DOI: 10.2174/2212697X03666160218215744



Review Article

Efficacy of Therapy with c-Met/HGF Inhibitors in Solid Tumors: A Systematic Review Based on 24 Clinical Trials

, 3(2): 87 - 99

Yin Yin, He Wang, Mingjie Lu and Wei Zhu


DOI: 10.2174/2212697X03666160805114707



Review Article

Efficacy of Bacteria in Cancer Immunotherapy: Special Emphasis on the Potential of Mycobacterial Species

, 3(2): 100 - 108

Santosh Podder, Srabanti Rakshit, Manikandan Ponnusamy and Dipankar Nandi


DOI: 10.2174/2212697X03666160824130123



Research Article

Ameliorated Chemotherapeutic Potential of Diverse Dose Flouropyrimidine Therapy By Etodolac via NF-κB Pathway, PPAR-γ Expression and COX-II Inhibition in DMH Induced Colon Cancer Rats

, 3(2): 109 - 120

Honey Goel, Kulbhushan Tikoo, Pinakin Arun Karpe, Richu Singla and Vivek Ranjan Sinha


DOI: 10.2174/2212697X03666160118233255



Research Article

Evaluation of Antitumor Potential of Forskolin and Andrographolide Employing Potato Tumor Bioassay Model

, 3(2): 121 - 130

Velpula Suresh, D. Raju, Rupula Karuna, Godugu Deepika and Sashidhar R. B


DOI: 10.2174/2212697X03666160524161911



Research Article

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

, 3(2): 131 - 137

G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken


DOI: 10.2174/2212697X03666160610085943



Research Article

Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells

, 3(2): 138 - 146

Yahaira Santiago-Vázquez, Umashankar Das, Armando Varela-Ramirez, Sarah T. Baca, Yoshira Ayala-Marin, Carolina Lema, Swagatika Das, Alaa Baryyan, Jonathan R. Dimmock and Renato J. Aguilera


DOI: 10.2174/2212697X03666160830165250






Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
USA

Biography View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog